Witness Testimony Regarding Intent to Infringe Excluded Because Defendant Refused Such Discovery Based on Privilege

Jan 17, 2023

Reading Time : 2 min

By: Jason Weil, Rachel J. Elsby, Lisa Hladik (Law Clerk)

In this case, plaintiffs alleged that defendant’s generic drug infringed its patent covering a method of treating hair loss. Before trial, plaintiffs filed two motions in limine seeking to exclude (1) evidence of prior litigation and (2) evidence related to defendant’s intent to infringe. The court granted plaintiffs’ first motion in limine to exclude evidence of the prior lawsuits because, inter alia, the evidence was more prejudicial than probative.

In the second motion in limine, plaintiffs moved to exclude defendant’s evidence relating to its executives’ “business understanding” as to whether it was entitled to practice the methods claimed in the asserted patent. Plaintiffs argued that the executives obtained their understanding from legal counsel, and that it should be excluded because defendant refused discovery of the same evidence based on privileged. The defendant responded that its executives’ understanding was based on public information, including the litigation history between the parties, and therefore did not fall within the scope of information it previously withheld as privileged.

To evaluate the arguments, the district court grouped the evidence defendants sought to introduce into three categories: (1) statements that the plaintiffs had “thrown in the towel” after losing three previous lawsuits between the parties, (2) statements by the defendant’s legal department giving it the go-ahead to launch its generic product and (3) statements related to the outcome of the prior litigation. According to the district court, the evidence in each category would only be admissible if it was either the subject of a waiver or not derived from advice of counsel.

As to the first two categories of evidence, the district court found the statements were clearly derived from advice of counsel. In particular, defendant’s understanding that plaintiffs were “throwing in the towel” and that it had the “green light” to practice the claims was not public information, and must have been obtained from counsel. Because defendant refused discovery into advice it received from counsel, it was precluded from presenting testimony from its executives about their “business understanding” of that advice at trial. As to the third category, the district court found the executives’ understanding regarding the outcome of prior litigation was based on public information, and therefore not privileged even if obtained from counsel. But that finding did not save defendant because the district court separately excluded testimony related to prior litigation through plaintiffs’ first motion in limine.

Practice Tip: In cases involving allegations of willful, contributory or induced infringement, defendants face a difficult choice of whether to waive privilege or potentially face trial without exculpatory evidence regarding their scienter. Thus, it is important to develop an early understanding of the evidence that may be relied on to negate allegations of intent and the source of that evidence to make informed decisions related to privilege during discovery. Likewise, patentees should take deliberate steps in discovery to ensure that defendants are forced to choose whether to waive privilege or forego such evidence.

Share This Insight

Previous Entries

IP Newsflash

August 11, 2025

In considering a motion to dismiss infringement claims for two related patents, the District of Massachusetts recently held that pre-suit knowledge of a “parent” patent, without more, is insufficient to establish pre-suit knowledge of the “child” patent for purposes of indirect and willful infringement.

...

Read More

IP Newsflash

August 8, 2025

Following a jury verdict finding trade secret misappropriation, the District Court for the District of Massachusetts granted-in-part a plaintiff’s motion for a permanent injunction to prohibit defendants from using plaintiff’s trade secrets. The district court further required defendants to reassign to plaintiff patents and patent applications that disclosed or were derived from plaintiff’s trade secrets as part of its equitable relief.

...

Read More

IP Newsflash

August 6, 2025

In ruling on a recent motion to strike, a judge in the Eastern District of Texas permitted a damages expert to rely on a damages theory based on defendant’s “avoided costs,” holding that this theory did not run afoul of the “entire market value rule.”

...

Read More

IP Newsflash

August 5, 2025

The Federal Circuit recently vacated a decision by the Patent Trial and Appeal Board after concluding that the board’s analysis of licensing evidence offered as a secondary consideration of nonobviousness constituted legal error and was not supported by substantial evidence. According to the court, the board applied a more exacting and improperly heightened nexus standard than is required by law for license evidence.

...

Read More

IP Newsflash

August 5, 2025

A Northern District of California judge recently granted a motion to reconsider his summary judgment ruling that defendant was barred from raising certain “device art” due to IPR estoppel under 35 U.S.C. § 315(e)(2). In the original ruling, the judge adopted the broader rule that IPR estoppel applies to device art that is “materially identical” to patents or printed publications that petitioners raised, or could have raised, in an IPR. Following that ruling, however, the Federal Circuit issued its Ingenico decision adopting the narrower view that IPR estoppel applies only to “grounds” based on patents and printed publications and not to device-based grounds. Citing Ingenico as a “change of law,” defendant moved for reconsideration of the court’s ruling, and the court granted the motion.

...

Read More

IP Newsflash

August 5, 2025

In a recent decision designated as Informative, the USPTO Director determined that the Patent Trial and Appeal Board abused its discretion by instituting two inter partes review proceedings challenging the same patent, based on petitions advancing different constructions of the same claim term. The Director expressed concerns that permitting multiple petitions based on alternative claim constructions effectively circumvents word count limitations, strains board resources, and undermines procedural efficiency.

...

Read More

IP Newsflash

July 25, 2025

Earlier this year, the Federal Circuit’s decision in Qualcomm Inc. v. Apple Inc. (Qualcomm II) raised questions about the extent to which petitioners can rely on applicant admitted prior art (“AAPA”) in inter partes review proceedings.  The Federal Circuit’s recent decision in Shockwave Medical, Inc. v. Cardiovascular Sys., Inc. largely cabins the Qualcomm II decision to its particular facts and makes clear that AAPA can be used as evidence of background knowledge as part of an obviousness argument.

...

Read More

IP Newsflash

July 11, 2025

The Federal Circuit recently reversed a PTAB determination on remand that a patent was obvious over applicant admitted prior art (“AAPA”) in combination with prior art patents, holding that expressly designating AAPA as a “basis” for a ground is improper under 35 U.S.C. § 311(b). In doing so, the Court rejected the PTAB’s “blanket rule” that “AAPA used in combination with prior art patents or printed publications under § 311(b) is ipso facto not the basis or part of the basis of a ground.” Ultimately, while the case clarifies that expressly listing AAPA in an IPR ground is improper, the precise line between proper and improper uses of AAPA in other instances remains unclear.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.